Americas Nuclear Medicines Market: Market Size, Forecast, Insights, and Competitive Landscape
The Americas nuclear medicines market is expected to grow at a CAGR of around 5.7% during 2023-2030. This report on Americas nuclear medicines market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the Americas nuclear medicines market by categorising the market based on various segments including detailed regional segmentation. Also, detailed profiles of companies operating in the Americas nuclear medicines market are provided in this report, which includes company description, business overview, product portfolio, and financial details.
This report provides an in-depth analysis of overall market and its segments. The historic numbers and forecasts are provided for each of the segments and for the countries covered in the report. This report also includes a detailed impact of COVID-19 pandemic on the Americas nuclear medicines market.
Apart from the quantitative analysis, the report also provides qualitative analysis, including SWOT analysis, porter’s five forces, and value chain of the industry. It also includes descriptive market drivers, opportunities, on-going & future trends, and challenges.
We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Historical & Forecast Period
Base Year: 2022
Historical Period: 2018-2022
Forecast Period: 2023-2030
Market by Application:
Research Methodology:
During the course of the research study, we conducted extensive primary and secondary research on the Americas nuclear medicine market. The research commenced with extensive exploration through secondary sources followed by primary research. With these research methods, we were able to estimate the market size, to identify the factors that promote the growth in this market as well as the factors that hamper growth in the market.
Comprehensive primary and secondary methods helped us to identify trends in the market and to project the opportunities that the key players may get during the forecast period. Apart from these approaches, various analytical and statistical approaches were also used during data extraction cleaning, and analysis.
Post secondary & primary research, we conducted expert interviews to validate all the information we collected during the course of the study. So, a blend of these three-way approaches helped us in data triangulation and to provide accurate market scenario in our report.
Key Highlights of Report:
This report provides an in-depth analysis of overall market and its segments. The historic numbers and forecasts are provided for each of the segments and for the countries covered in the report. This report also includes a detailed impact of COVID-19 pandemic on the Americas nuclear medicines market.
Apart from the quantitative analysis, the report also provides qualitative analysis, including SWOT analysis, porter’s five forces, and value chain of the industry. It also includes descriptive market drivers, opportunities, on-going & future trends, and challenges.
We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Historical & Forecast Period
Base Year: 2022
Historical Period: 2018-2022
Forecast Period: 2023-2030
Market by Application:
- Cardiology
- Neurology
- Oncology
- Other
- Diagnostics
- Single Photon Emission Computed Tomography (SPECT)
- Positron Emission Tomography (PET)
- Therapeutics
- Alpha Emitters
- Beta Emitters
- Brachytherapy
- North America
- United States
- Canada
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Cardinal Health
- GE Healthcare
- Curium
- Lantheus Medical Imaging, Inc.
- Bayer AG
- Bracco Imaging S.P.A
- Hologic Inc.
- Medix Inc.
- Segami Corporation
- Positron Corporation
Research Methodology:
During the course of the research study, we conducted extensive primary and secondary research on the Americas nuclear medicine market. The research commenced with extensive exploration through secondary sources followed by primary research. With these research methods, we were able to estimate the market size, to identify the factors that promote the growth in this market as well as the factors that hamper growth in the market.
Comprehensive primary and secondary methods helped us to identify trends in the market and to project the opportunities that the key players may get during the forecast period. Apart from these approaches, various analytical and statistical approaches were also used during data extraction cleaning, and analysis.
Post secondary & primary research, we conducted expert interviews to validate all the information we collected during the course of the study. So, a blend of these three-way approaches helped us in data triangulation and to provide accurate market scenario in our report.
Key Highlights of Report:
- Overview of Americas nuclear medicines market.
- Analysis of Americas market trends, historical data, market estimates for the base year, and projections of compound annual growth rates (CAGRs) through the forecast period
- Profiles of the key companies
- SWOT analysis, Porter’s five forces, and value chain analysis of nuclear medicines market
- What will be the Americas nuclear medicines market size and the growth rate in the coming year?
- What are the main key factors driving the market?
- What are the key market trends impacting the growth of the market?
- What are the market opportunities and threats in the market?
- What industrial trends, drivers and challenges are manipulating its growth?
- Which are trending factors influencing the market shares of the top regions across the America?
- Who are the key market players in the industry?
- What is the degree of competition in the industry?
- What is the impact of Covid19 on the current industry?
1. PREFACE
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. KEY INSIGHTS
3. AMERICAS NUCLEAR MEDICINES MARKET
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. AMERICAS NUCLEAR MEDICINES MARKET ANALYSIS
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. AMERICAS NUCLEAR MEDICINES MARKET BY APPLICATION
5.1. Introduction
5.2. Cardiology
5.3. Neurology
5.4. Oncology
5.5. Other
6. AMERICAS NUCLEAR MEDICINES MARKET BY PRODUCT TYPE
6.1. Introduction
6.2. Diagnostics
6.2.1. Single Photon Emission Computed Tomography (SPECT)
6.2.2. Positron Emission Tomography (PET)
6.3. Therapeutics
6.3.1. Alpha Emitters
6.3.2. Beta Emitters
6.3.3. Brachytherapy
7. AMERICAS NUCLEAR MEDICINES MARKET BY COUNTRY
7.1. Introduction
7.2. North America
7.2.1. United States
7.2.2. Canada
7.3. Latin America
7.3.1. Mexico
7.3.2. Brazil
7.3.3. Argentina
7.3.4. Rest of Latin America
8. SWOT ANALYSIS
9. PORTER’S FIVE FORCES
10. MARKET VALUE CHAIN ANALYSIS
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Company Profiles
11.2.1. Cardinal Health
11.2.2. GE Healthcare
11.2.3. Curium
11.2.4. Lantheus Medical Imaging, Inc.
11.2.5. Bayer AG
11.2.6. Bracco Imaging S.P.A
11.2.7. Hologic Inc.
11.2.8. Medix Inc.
11.2.9. Segami Corporation
11.2.10. Positron Corporation
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. KEY INSIGHTS
3. AMERICAS NUCLEAR MEDICINES MARKET
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. AMERICAS NUCLEAR MEDICINES MARKET ANALYSIS
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. AMERICAS NUCLEAR MEDICINES MARKET BY APPLICATION
5.1. Introduction
5.2. Cardiology
5.3. Neurology
5.4. Oncology
5.5. Other
6. AMERICAS NUCLEAR MEDICINES MARKET BY PRODUCT TYPE
6.1. Introduction
6.2. Diagnostics
6.2.1. Single Photon Emission Computed Tomography (SPECT)
6.2.2. Positron Emission Tomography (PET)
6.3. Therapeutics
6.3.1. Alpha Emitters
6.3.2. Beta Emitters
6.3.3. Brachytherapy
7. AMERICAS NUCLEAR MEDICINES MARKET BY COUNTRY
7.1. Introduction
7.2. North America
7.2.1. United States
7.2.2. Canada
7.3. Latin America
7.3.1. Mexico
7.3.2. Brazil
7.3.3. Argentina
7.3.4. Rest of Latin America
8. SWOT ANALYSIS
9. PORTER’S FIVE FORCES
10. MARKET VALUE CHAIN ANALYSIS
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Company Profiles
11.2.1. Cardinal Health
11.2.2. GE Healthcare
11.2.3. Curium
11.2.4. Lantheus Medical Imaging, Inc.
11.2.5. Bayer AG
11.2.6. Bracco Imaging S.P.A
11.2.7. Hologic Inc.
11.2.8. Medix Inc.
11.2.9. Segami Corporation
11.2.10. Positron Corporation
LIST OF TABLES
Table 1: Americas Nuclear Medicine Market Portraiture
Table 2: Americas Nuclear Medicine Market by Application (in US$ Million), 2022 & 2030
Table 3: Americas Nuclear Medicine Market by Product Type (in US$ Million), 2022 & 2030
Table 4: Americas Diagnostics Nuclear Medicine Market by Product Type (in US$ Million), 2022 & 2030
Table 5: Americas Therapeutics Nuclear Medicine Market by Product Type (in US$ Million), 2022 & 2030
Table 6: Americas Nuclear Medicine Market by Region (in US$ Million), 2022 & 2030
Table 7: North America Nuclear Medicine Market by Country (in US$ Million), 2022 & 2030
Table 8: Latin America Nuclear Medicine Market by Country (in US$ Million), 2022 & 2030
Table 9: List of Key Players
Table 1: Americas Nuclear Medicine Market Portraiture
Table 2: Americas Nuclear Medicine Market by Application (in US$ Million), 2022 & 2030
Table 3: Americas Nuclear Medicine Market by Product Type (in US$ Million), 2022 & 2030
Table 4: Americas Diagnostics Nuclear Medicine Market by Product Type (in US$ Million), 2022 & 2030
Table 5: Americas Therapeutics Nuclear Medicine Market by Product Type (in US$ Million), 2022 & 2030
Table 6: Americas Nuclear Medicine Market by Region (in US$ Million), 2022 & 2030
Table 7: North America Nuclear Medicine Market by Country (in US$ Million), 2022 & 2030
Table 8: Latin America Nuclear Medicine Market by Country (in US$ Million), 2022 & 2030
Table 9: List of Key Players
LIST OF FIGURES
Figure 1: Americas Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 2: Americas Nuclear Medicine Market by Application, 2022
Figure 3: Americas Nuclear Medicine Market by Product Type, 2022
Figure 4: Americas Nuclear Medicine Market by Region, 2022
Figure 5: Americas Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 6: Americas Nuclear Medicine Market by Application (in %), 2022 & 2030
Figure 7: Americas Cardiology Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 8: Americas Cardiology Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 9: Americas Neurology Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 10: Americas Neurology Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 11: Americas Oncology Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 12: Americas Oncology Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 13: Americas Other Applications Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 14: Americas Other Applications Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 15: Americas Nuclear Medicine Market by Product Type (in %), 2022 & 2030
Figure 16: Americas Diagnostics Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 17: Americas Diagnostics Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 18: Single Photon Emission Computed Tomography (SPECT) Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 19: Positron Emission Tomography (PET) Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 20: Americas Therapeutics Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 21: Americas Therapeutics Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 22: Alpha Emitters Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 23: Beta Emitters Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 24: Brachytherapy Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 25: Americas Nuclear Medicine Market by Region (in %), 2022 & 2030
Figure 26: North America Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 27: North America Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 28: North America Nuclear Medicine Market by Country (in %), 2022 & 2030
Figure 29: United State Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 30: Canada Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 31: Latin America Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 32: Latin America Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 33: Latin America Nuclear Medicine Market by Country (in %), 2022 & 2030
Figure 34: Mexico Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 35: Brazil Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 36: Argentina Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 37: Rest of Latin America Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 38: Market Value Chain
Figure 1: Americas Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 2: Americas Nuclear Medicine Market by Application, 2022
Figure 3: Americas Nuclear Medicine Market by Product Type, 2022
Figure 4: Americas Nuclear Medicine Market by Region, 2022
Figure 5: Americas Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 6: Americas Nuclear Medicine Market by Application (in %), 2022 & 2030
Figure 7: Americas Cardiology Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 8: Americas Cardiology Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 9: Americas Neurology Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 10: Americas Neurology Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 11: Americas Oncology Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 12: Americas Oncology Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 13: Americas Other Applications Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 14: Americas Other Applications Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 15: Americas Nuclear Medicine Market by Product Type (in %), 2022 & 2030
Figure 16: Americas Diagnostics Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 17: Americas Diagnostics Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 18: Single Photon Emission Computed Tomography (SPECT) Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 19: Positron Emission Tomography (PET) Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 20: Americas Therapeutics Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 21: Americas Therapeutics Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 22: Alpha Emitters Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 23: Beta Emitters Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 24: Brachytherapy Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 25: Americas Nuclear Medicine Market by Region (in %), 2022 & 2030
Figure 26: North America Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 27: North America Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 28: North America Nuclear Medicine Market by Country (in %), 2022 & 2030
Figure 29: United State Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 30: Canada Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 31: Latin America Nuclear Medicine Market (in US$ Million), 2018-2022
Figure 32: Latin America Nuclear Medicine Market (in US$ Million), 2023-2030
Figure 33: Latin America Nuclear Medicine Market by Country (in %), 2022 & 2030
Figure 34: Mexico Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 35: Brazil Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 36: Argentina Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 37: Rest of Latin America Nuclear Medicine Market (in US$ Million), 2018-2030
Figure 38: Market Value Chain
